Prof. Dr. Abhay H Pande, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India

Abhay H Pande is a distinguished professor at the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab. He leads the Protein Biopharmaceutical Lab, where his work focuses on the development of innovative biopharmaceuticals targeting inflammatory disorders, cancer, and bioterrorism defense. Notable advancements include the development of bispecific antibodies and prophylactic biologics like LBUPON™. With 18 patents and over 80 scientific publications, Pande’s research has gained global recognition. He is also deeply committed to bridging academia and industry, playing a key role in incubation initiatives such as CPIE and BioNEST. His passion for teaching is reflected in his contributions to curriculum development and mentoring numerous Ph.D. and Master’s students. Pande is recognized for his leadership in pharmaceutical innovation, sustainability, and promoting biotechnology’s role in global health solutions.

Summary of Suitability for the Award

Dr. Abhay H. Pande is highly suitable for the Research for Best Researcher Award based on his extensive and impactful contributions to the field of biopharmaceuticals. As a professor at the National Institute of Pharmaceutical Education and Research (NIPER), his innovative research focuses on developing novel biologics for critical healthcare challenges, including cancer, inflammatory diseases, and bioterrorism defense. His work has led to the development of pioneering biologics such as BiSpekDAb™, ApoEFrag™, and LBUPON™, which are in advanced pre-clinical stages, showcasing his expertise in translating scientific discoveries into real-world solutions.

Education

Abhay H Pande completed his education in biopharmaceutical sciences, with a strong emphasis on biotechnology and pharmaceutical development. His academic journey equipped him with the knowledge and skills to develop biopharmaceutical solutions to address global healthcare challenges. Over the years, he has designed comprehensive curricula for M.Tech programs in Biopharmaceuticals and Medical Devices, reflecting his expertise in interdisciplinary fields like biochemistry, biotechnology, immunology, and cell biology. Pande’s academic foundation and continuous learning have fueled his innovative work in developing therapeutics for cancer, inflammatory disorders, and bioterrorism defense. His teaching and curriculum design efforts further demonstrate his dedication to education and the dissemination of biopharmaceutical knowledge.

Experience

Abhay H Pande has over two decades of experience in the pharmaceutical and biotechnology fields, currently serving as a professor at NIPER. He has led numerous research projects aimed at developing innovative biologics, such as bispecific antibodies and anticancer biologics. Pande has also held leadership roles as the chairman of the CPIE-Incubation Center and project coordinator for BioNEST, where he fosters collaboration between academia and industry. His experience includes teaching courses in Biochemistry, Biotechnology, Immunology, and Cell Biology, as well as supervising the research of 9 Ph.D. scholars and 138 master’s theses. His contributions span across research, innovation, and academic leadership.

Awards and Honors

Abhay H Pande has been recognized for his groundbreaking work in biopharmaceuticals through numerous awards and honors. He has secured 18 patents for his innovative biologics and therapeutic developments. His research contributions have been honored at prestigious national forums, reflecting the widespread recognition of his work. Additionally, Pande has been invited to deliver lectures globally on biotechnology’s role in sustainability and healthcare. As a leader in pharmaceutical education, he has received accolades for his role in fostering academia-industry collaboration, mentoring students, and advancing innovative research in biotechnology.

Research Focus

Abhay H Pande’s research focuses on the development of innovative biopharmaceutical solutions to address global healthcare challenges. His work primarily targets inflammatory disorders, cancer, and bioterrorism defense. Key innovations include the development of bispecific antibodies (BiSpekDAb™) and prophylactic biologics (LBUPON™). Pande’s research also explores enzyme-based therapies for cardiovascular disorders, cancer treatment, and nerve agent poisoning. He collaborates with national and international research institutions, focusing on creating sustainable, scalable solutions for biopharmaceutical challenges. His research not only addresses urgent healthcare needs but also aims to make significant contributions to global sustainability through biotechnology.

Publication Top Notes

Title: Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase

Citations: 141

Title: Conformational instability of the cholera toxin A1 polypeptide

Citations: 92

Title: Studies on a Doubleheaded Protease Inhibitor from Phaseolus mungo

Citations: 65

Title: Modulation of human 5-lipoxygenase activity by membrane lipids

Citations: 62

Title: The N-terminal α-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface

Citations: 60

Dr. Stela Dragomanova| Neuroscience | Best Researcher Award

Dr. Stela Dragomanova, Medical University of Varna, Bulgaria

Dr. Stela Dragomanova is a distinguished researcher and educator at the Medical University of Varna. She earned her master’s degree in Pharmacy from the Medical University of Sofia in 2004 and later specialized in Clinical Pharmacy. In 2020, she completed her Ph.D. in Pharmacology at the Institute of Neurobiology, Bulgarian Academy of Sciences. Dr. Dragomanova’s research centers on neuropharmacology, particularly neurodegenerative diseases. She is a member of the Bulgarian Pharmaceutical Union and serves as Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna. Dr. Dragomanova has published 30+ peer-reviewed papers, contributing significantly to pharmacology and neuroscience. She has also served as Assistant Professor from 2010 to 2021 and is currently Chief Assistant Professor in the Department of Pharmacology at the Medical University of Varna.

Professional Profile

Orcid

Summary of Suitability for the Research for Best Researcher Award

Dr. Stela Dragomanova demonstrates a strong profile as a candidate for the Research for Best Researcher Award. With a Ph.D. in Pharmacology and a focus on neuropharmacology, her research is centered around neurodegenerative diseases, a critical area of biomedical research. Her expertise in in vivo preclinical models and behavioral tests positions her as a valuable contributor to the scientific community, particularly in neuropharmacology and toxicology.Her academic career includes over a decade of teaching and research at the Medical University of Varna, Bulgaria, where she has steadily advanced from Assistant Professor to Chief Assistant Professor. Dr. Dragomanova has also made substantial contributions to the scientific literature, with 30+ publications, including articles in high-impact journals such as Antioxidants and Molecules, with topics addressing neuroprotective strategies and experimental pharmacology.

Education

Dr. Stela Dragomanova began her academic journey at the Medical University of Sofia, where she obtained her master’s degree in Pharmacy in 2004. She further specialized in Clinical Pharmacy, enhancing her expertise in pharmacological interventions. Driven by her passion for neuropharmacology, Dr. Dragomanova pursued her Ph.D. in Pharmacology at the Bulgarian Academy of Sciences’ Institute of Neurobiology, completing it in 2020. Her doctoral research provided significant insights into neurodegenerative diseases and related pharmacotherapies. With a strong foundation in experimental pharmacology and toxicology, Dr. Dragomanova is equipped with advanced skills in preclinical in vivo models and behavioral testing. Her academic qualifications, coupled with her research experience, reflect her commitment to advancing knowledge in the pharmaceutical and neuropharmacological fields.

Experience

Dr. Stela Dragomanova has been an integral part of the Medical University of Varna since 2010, starting as an Assistant Professor in the Department of Pharmacology, Toxicology, and Pharmacotherapy. She transitioned into the role of Chief Assistant Professor in 2021, where she continues to lead and mentor young scientists in neuropharmacology. In her academic career, she has overseen numerous research projects focusing on neurodegenerative disorders, particularly in exploring neuroprotective agents and pharmacological treatments. She has extensive expertise in in vivo preclinical models and behavioral testing in experimental pharmacology. Dr. Dragomanova is also deeply involved in regulatory and ethical aspects of pharmacology research, serving as the Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna and being an active member of several scientific and pharmaceutical associations.

Awards and Honors

Dr. Stela Dragomanova has been recognized for her outstanding contributions to the field of pharmacology and her dedication to healthcare and education. In 2018, she was named “Pharmacist of the Year” for the Varna region by the Regional Pharmaceutical Collegium. This prestigious award highlights her commitment to the pharmaceutical profession and the positive impact of her work in the healthcare sector. In addition to her regional recognition, Dr. Dragomanova is an esteemed member of the Bulgarian Pharmaceutical Union, which is part of the Pharmaceutical Group of the European Union (PGEU). She also holds leadership roles in several academic and professional organizations, including the Bulgarian Association of Pharmacology, Clinical Pharmacology, and Therapeutics. Her extensive experience in both research and education further solidifies her as a prominent figure in the pharmacological sciences.

Research Focus

Dr. Stela Dragomanova’s research is primarily focused on neuropharmacology, particularly in understanding the mechanisms underlying neurodegenerative diseases. Her work aims to discover potential therapeutic agents that can mitigate the progression of disorders such as Alzheimer’s and Parkinson’s disease. She has developed expertise in using in vivo preclinical models to evaluate neuroprotective compounds and conduct behavioral tests. Her research explores the role of antioxidants and polyphenols, studying their neuroprotective effects and potential applications in pharmacotherapy. Additionally, Dr. Dragomanova is interested in the therapeutic potential of lipid emulsions in treating convulsions and other toxicological conditions. Her investigations have led to a deeper understanding of the molecular and biochemical processes that drive neurodegeneration, with a strong focus on developing novel interventions for these challenging medical conditions.

Publications Top Notes

Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
Trehalose: Neuroprotective Effects and Mechanisms—An Updated Review
Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
Neuropharmacological investigation of myrtenal conjugates with aminoadamantane
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2

Prof. Dr. Abhay H Pande | Biotechnology | Best Researcher Award